Form 8-K - Current report:
SEC Accession No. 0001935979-26-000060
Filing Date
2026-08-07
Accepted
2026-08-07 16:10:34
Documents
11
Period of Report
2026-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20260803.htm   iXBRL 8-K 23207
  Complete submission text file 0001935979-26-000060.txt   136951

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20260803.xsd EX-101.SCH 1803
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20260803_lab.xml EX-101.LAB 21597
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20260803_pre.xml EX-101.PRE 12510
15 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20260803_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 261254081
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)